ID   CSF1R_RAT               Reviewed;         978 AA.
AC   Q00495;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1993, sequence version 1.
DT   02-OCT-2024, entry version 183.
DE   RecName: Full=Macrophage colony-stimulating factor 1 receptor;
DE   AltName: Full=CSF-1 receptor;
DE            Short=CSF-1-R;
DE            Short=CSF-1R;
DE            Short=M-CSF-R;
DE            EC=2.7.10.1;
DE   AltName: Full=Proto-oncogene c-Fms;
DE   AltName: CD_antigen=CD115;
DE   Flags: Precursor;
GN   Name=Csf1r; Synonyms=Csfmr, Fms;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Wistar; TISSUE=Skeletal muscle;
RX   PubMed=1389227; DOI=10.3109/08977199209026928;
RA   Borycki A.G., Guillier M., Leibovitch M.P., Leibovitch S.A.;
RT   "Molecular cloning of CSF-1 receptor from rat myoblasts. Sequence analysis
RT   and regulation during myogenesis.";
RL   Growth Factors 6:209-218(1992).
RN   [2]
RP   FUNCTION IN BONE RESORPTION.
RX   PubMed=17121910; DOI=10.1158/1535-7163.mct-05-0313;
RA   Ohno H., Kubo K., Murooka H., Kobayashi Y., Nishitoba T., Shibuya M.,
RA   Yoneda T., Isoe T.;
RT   "A c-fms tyrosine kinase inhibitor, Ki20227, suppresses osteoclast
RT   differentiation and osteolytic bone destruction in a bone metastasis
RT   model.";
RL   Mol. Cancer Ther. 5:2634-2643(2006).
CC   -!- FUNCTION: Tyrosine-protein kinase that acts as a cell-surface receptor
CC       for CSF1 and IL34 and plays an essential role in the regulation of
CC       survival, proliferation and differentiation of hematopoietic precursor
CC       cells, especially mononuclear phagocytes, such as macrophages and
CC       monocytes. Promotes the release of pro-inflammatory chemokines in
CC       response to IL34 and CSF1, and thereby plays an important role in
CC       innate immunity and in inflammatory processes. Plays an important role
CC       in the regulation of osteoclast proliferation and differentiation, the
CC       regulation of bone resorption, and is required for normal bone and
CC       tooth development. Required for normal male and female fertility, and
CC       for normal development of milk ducts and acinar structures in the
CC       mammary gland during pregnancy. Promotes reorganization of the actin
CC       cytoskeleton, regulates formation of membrane ruffles, cell adhesion
CC       and cell migration, and promotes cancer cell invasion. Activates
CC       several signaling pathways in response to ligand binding, including the
CC       ERK1/2 and the JNK pathway (By similarity). Phosphorylates PIK3R1,
CC       PLCG2, GRB2, SLA2 and CBL. Activation of PLCG2 leads to the production
CC       of the cellular signaling molecules diacylglycerol and inositol 1,4,5-
CC       trisphosphate, that then lead to the activation of protein kinase C
CC       family members, especially PRKCD. Phosphorylation of PIK3R1, the
CC       regulatory subunit of phosphatidylinositol 3-kinase, leads to
CC       activation of the AKT1 signaling pathway. Activated CSF1R also mediates
CC       activation of the MAP kinases MAPK1/ERK2 and/or MAPK3/ERK1, and of the
CC       SRC family kinases SRC, FYN and YES1. Activated CSF1R transmits signals
CC       both via proteins that directly interact with phosphorylated tyrosine
CC       residues in its intracellular domain, or via adapter proteins, such as
CC       GRB2. Promotes activation of STAT family members STAT3, STAT5A and/or
CC       STAT5B. Promotes tyrosine phosphorylation of SHC1 and INPP5D/SHIP-1.
CC       Receptor signaling is down-regulated by protein phosphatases, such as
CC       INPP5D/SHIP-1, that dephosphorylate the receptor and its downstream
CC       effectors, and by rapid internalization of the activated receptor (By
CC       similarity). In the central nervous system, may play a role in the
CC       development of microglia macrophages (By similarity).
CC       {ECO:0000250|UniProtKB:P07333, ECO:0000269|PubMed:17121910}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-tyrosyl-[protein] = ADP + H(+) + O-phospho-L-tyrosyl-
CC         [protein]; Xref=Rhea:RHEA:10596, Rhea:RHEA-COMP:10136, Rhea:RHEA-
CC         COMP:10137, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:46858,
CC         ChEBI:CHEBI:82620, ChEBI:CHEBI:456216; EC=2.7.10.1;
CC         Evidence={ECO:0000255|PROSITE-ProRule:PRU10028};
CC   -!- ACTIVITY REGULATION: Present in an inactive conformation in the absence
CC       of bound ligand. CSF1 or IL34 binding leads to dimerization and
CC       activation by autophosphorylation on tyrosine residues (By similarity).
CC       {ECO:0000250}.
CC   -!- SUBUNIT: Monomer. Homodimer. Interacts with CSF1 and IL34. Interaction
CC       with dimeric CSF1 or IL34 leads to receptor homodimerization. Interacts
CC       with INPPL1/SHIP2 and THOC5. Interacts (tyrosine phosphorylated) with
CC       PLCG2 (via SH2 domain). Interacts (tyrosine phosphorylated) with PIK3R1
CC       (via SH2 domain). Interacts (tyrosine phosphorylated) with FYN, YES1
CC       and SRC (via SH2 domain). Interacts (tyrosine phosphorylated) with CBL,
CC       GRB2 and SLA2 (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Single-pass type I membrane
CC       protein. Note=The autophosphorylated receptor is ubiquitinated and
CC       internalized, leading to its degradation. {ECO:0000250}.
CC   -!- DOMAIN: The juxtamembrane domain functions as autoinhibitory region.
CC       Phosphorylation of tyrosine residues in this region leads to a
CC       conformation change and activation of the kinase (By similarity).
CC       {ECO:0000250}.
CC   -!- DOMAIN: The activation loop plays an important role in the regulation
CC       of kinase activity. Phosphorylation of tyrosine residues in this region
CC       leads to a conformation change and activation of the kinase (By
CC       similarity). {ECO:0000250}.
CC   -!- PTM: Autophosphorylated in response to CSF1 or IL34 binding.
CC       Phosphorylation at Tyr-559 is important for normal down-regulation of
CC       signaling by ubiquitination, internalization and degradation.
CC       Phosphorylation at Tyr-559 and Tyr-807 is important for interaction
CC       with SRC family members, including FYN, YES1 and SRC, and for
CC       subsequent activation of these protein kinases. Phosphorylation at Tyr-
CC       697 and Tyr-921 is important for interaction with GRB2. Phosphorylation
CC       at Tyr-721 is important for interaction with PIK3R1. Phosphorylation at
CC       Tyr-721 and Tyr-807 is important for interaction with PLCG2.
CC       Phosphorylation at Tyr-974 is important for interaction with CBL.
CC       Dephosphorylation by PTPN2 negatively regulates downstream signaling
CC       and macrophage differentiation (By similarity). {ECO:0000250}.
CC   -!- PTM: Ubiquitinated. Becomes rapidly polyubiquitinated after
CC       autophosphorylation, leading to its degradation (By similarity).
CC       {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
CC       kinase family. CSF-1/PDGF receptor subfamily. {ECO:0000255|PROSITE-
CC       ProRule:PRU00159}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X61479; CAA43706.1; -; mRNA.
DR   PIR; I60321; S16385.
DR   AlphaFoldDB; Q00495; -.
DR   SMR; Q00495; -.
DR   STRING; 10116.ENSRNOP00000040411; -.
DR   BindingDB; Q00495; -.
DR   GlyCosmos; Q00495; 9 sites, No reported glycans.
DR   GlyGen; Q00495; 9 sites.
DR   iPTMnet; Q00495; -.
DR   PhosphoSitePlus; Q00495; -.
DR   UCSC; RGD:2425; rat.
DR   AGR; RGD:2425; -.
DR   RGD; 2425; Csf1r.
DR   InParanoid; Q00495; -.
DR   PhylomeDB; Q00495; -.
DR   BRENDA; 2.7.10.1; 5301.
DR   Reactome; R-RNO-449836; Other interleukin signaling.
DR   PRO; PR:Q00495; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0044297; C:cell body; IDA:RGD.
DR   GO; GO:0009986; C:cell surface; ISS:UniProtKB.
DR   GO; GO:1990682; C:CSF1-CSF1R complex; ISO:RGD.
DR   GO; GO:0016020; C:membrane; ISO:RGD.
DR   GO; GO:0043204; C:perikaryon; IDA:RGD.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0043235; C:receptor complex; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0019955; F:cytokine binding; ISS:UniProtKB.
DR   GO; GO:0019838; F:growth factor binding; IBA:GO_Central.
DR   GO; GO:0005011; F:macrophage colony-stimulating factor receptor activity; ISS:UniProtKB.
DR   GO; GO:0097159; F:organic cyclic compound binding; IPI:RGD.
DR   GO; GO:0042803; F:protein homodimerization activity; ISO:RGD.
DR   GO; GO:0019903; F:protein phosphatase binding; IPI:RGD.
DR   GO; GO:0004714; F:transmembrane receptor protein tyrosine kinase activity; ISO:RGD.
DR   GO; GO:0007411; P:axon guidance; ISO:RGD.
DR   GO; GO:0060038; P:cardiac muscle cell proliferation; IEP:RGD.
DR   GO; GO:0008283; P:cell population proliferation; ISO:RGD.
DR   GO; GO:0007169; P:cell surface receptor protein tyrosine kinase signaling pathway; ISS:UniProtKB.
DR   GO; GO:0045217; P:cell-cell junction maintenance; ISO:RGD.
DR   GO; GO:0071345; P:cellular response to cytokine stimulus; ISS:UniProtKB.
DR   GO; GO:0036006; P:cellular response to macrophage colony-stimulating factor stimulus; IEP:RGD.
DR   GO; GO:0071560; P:cellular response to transforming growth factor beta stimulus; IEP:RGD.
DR   GO; GO:0071356; P:cellular response to tumor necrosis factor; IEP:RGD.
DR   GO; GO:0019221; P:cytokine-mediated signaling pathway; ISO:RGD.
DR   GO; GO:0021542; P:dentate gyrus development; IMP:RGD.
DR   GO; GO:0021879; P:forebrain neuron differentiation; ISO:RGD.
DR   GO; GO:0030097; P:hemopoiesis; ISO:RGD.
DR   GO; GO:0045087; P:innate immune response; IEA:UniProtKB-KW.
DR   GO; GO:0038145; P:macrophage colony-stimulating factor signaling pathway; ISO:RGD.
DR   GO; GO:0014005; P:microglia development; IMP:RGD.
DR   GO; GO:0001774; P:microglial cell activation; IMP:RGD.
DR   GO; GO:0061518; P:microglial cell proliferation; IDA:RGD.
DR   GO; GO:0035702; P:monocyte homeostasis; IMP:RGD.
DR   GO; GO:1903131; P:mononuclear cell differentiation; IEP:RGD.
DR   GO; GO:0051450; P:myoblast proliferation; IEP:RGD.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; ISO:RGD.
DR   GO; GO:0008285; P:negative regulation of cell population proliferation; ISO:RGD.
DR   GO; GO:0030857; P:negative regulation of epithelial cell differentiation; IMP:RGD.
DR   GO; GO:0010832; P:negative regulation of myotube differentiation; IMP:RGD.
DR   GO; GO:1905220; P:negative regulation of platelet formation; IMP:RGD.
DR   GO; GO:1990138; P:neuron projection extension; IMP:RGD.
DR   GO; GO:0001780; P:neutrophil homeostasis; IMP:RGD.
DR   GO; GO:0021772; P:olfactory bulb development; ISO:RGD.
DR   GO; GO:0030316; P:osteoclast differentiation; HEP:RGD.
DR   GO; GO:0018108; P:peptidyl-tyrosine phosphorylation; ISS:UniProtKB.
DR   GO; GO:0044794; P:positive regulation by host of viral process; ISO:RGD.
DR   GO; GO:0061890; P:positive regulation of astrocyte activation; IMP:RGD.
DR   GO; GO:0030501; P:positive regulation of bone mineralization; IMP:RGD.
DR   GO; GO:1902808; P:positive regulation of cell cycle G1/S phase transition; IMP:RGD.
DR   GO; GO:0030335; P:positive regulation of cell migration; IBA:GO_Central.
DR   GO; GO:2000147; P:positive regulation of cell motility; ISO:RGD.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; ISS:UniProtKB.
DR   GO; GO:0032722; P:positive regulation of chemokine production; ISO:RGD.
DR   GO; GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; ISS:UniProtKB.
DR   GO; GO:0010628; P:positive regulation of gene expression; IMP:RGD.
DR   GO; GO:0070665; P:positive regulation of leukocyte proliferation; IMP:RGD.
DR   GO; GO:0050671; P:positive regulation of lymphocyte proliferation; IMP:RGD.
DR   GO; GO:0010759; P:positive regulation of macrophage chemotaxis; ISO:RGD.
DR   GO; GO:1905523; P:positive regulation of macrophage migration; IMP:RGD.
DR   GO; GO:0120041; P:positive regulation of macrophage proliferation; IMP:RGD.
DR   GO; GO:2000288; P:positive regulation of myoblast proliferation; IMP:RGD.
DR   GO; GO:0045672; P:positive regulation of osteoclast differentiation; IMP:RGD.
DR   GO; GO:0051897; P:positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction; ISS:UniProtKB.
DR   GO; GO:0001934; P:positive regulation of protein phosphorylation; ISO:RGD.
DR   GO; GO:0032760; P:positive regulation of tumor necrosis factor production; IMP:RGD.
DR   GO; GO:0042531; P:positive regulation of tyrosine phosphorylation of STAT protein; ISS:UniProtKB.
DR   GO; GO:0046777; P:protein autophosphorylation; ISS:UniProtKB.
DR   GO; GO:0032956; P:regulation of actin cytoskeleton organization; ISS:UniProtKB.
DR   GO; GO:0045124; P:regulation of bone resorption; IMP:UniProtKB.
DR   GO; GO:0008360; P:regulation of cell shape; ISS:UniProtKB.
DR   GO; GO:1905521; P:regulation of macrophage migration; ISS:UniProtKB.
DR   GO; GO:0043408; P:regulation of MAPK cascade; IBA:GO_Central.
DR   GO; GO:0032944; P:regulation of mononuclear cell proliferation; IMP:RGD.
DR   GO; GO:0048678; P:response to axon injury; IEP:RGD.
DR   GO; GO:0001666; P:response to hypoxia; IEP:RGD.
DR   GO; GO:0002931; P:response to ischemia; ISO:RGD.
DR   GO; GO:0032496; P:response to lipopolysaccharide; IEP:RGD.
DR   GO; GO:0009612; P:response to mechanical stimulus; IEP:RGD.
DR   GO; GO:0014070; P:response to organic cyclic compound; IEP:RGD.
DR   GO; GO:0031529; P:ruffle organization; ISS:UniProtKB.
DR   GO; GO:0014856; P:skeletal muscle cell proliferation; IEP:RGD.
DR   GO; GO:0007519; P:skeletal muscle tissue development; IEP:RGD.
DR   CDD; cd05106; PTKc_CSF-1R; 1.
DR   Gene3D; 2.60.40.10; Immunoglobulins; 5.
DR   Gene3D; 1.10.510.10; Transferase(Phosphotransferase) domain 1; 1.
DR   InterPro; IPR030658; CSF-1_receptor.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   InterPro; IPR013151; Immunoglobulin_dom.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR050122; RTK.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   InterPro; IPR008266; Tyr_kinase_AS.
DR   InterPro; IPR020635; Tyr_kinase_cat_dom.
DR   InterPro; IPR001824; Tyr_kinase_rcpt_3_CS.
DR   PANTHER; PTHR24416:SF47; MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR; 1.
DR   PANTHER; PTHR24416; TYROSINE-PROTEIN KINASE RECEPTOR; 1.
DR   Pfam; PF00047; ig; 1.
DR   Pfam; PF07714; PK_Tyr_Ser-Thr; 1.
DR   PIRSF; PIRSF500947; CSF-1_receptor; 1.
DR   PIRSF; PIRSF000615; TyrPK_CSF1-R; 1.
DR   SMART; SM00409; IG; 5.
DR   SMART; SM00408; IGc2; 2.
DR   SMART; SM00219; TyrKc; 1.
DR   SUPFAM; SSF48726; Immunoglobulin; 5.
DR   SUPFAM; SSF56112; Protein kinase-like (PK-like); 1.
DR   PROSITE; PS50835; IG_LIKE; 4.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
DR   PROSITE; PS00240; RECEPTOR_TYR_KIN_III; 1.
PE   1: Evidence at protein level;
KW   ATP-binding; Cell membrane; Disulfide bond; Glycoprotein; Immunity;
KW   Immunoglobulin domain; Inflammatory response; Innate immunity; Kinase;
KW   Membrane; Nucleotide-binding; Phosphoprotein; Proto-oncogene; Receptor;
KW   Reference proteome; Repeat; Signal; Transferase; Transmembrane;
KW   Transmembrane helix; Tyrosine-protein kinase; Ubl conjugation.
FT   SIGNAL          1..19
FT                   /evidence="ECO:0000250"
FT   CHAIN           20..978
FT                   /note="Macrophage colony-stimulating factor 1 receptor"
FT                   /id="PRO_0000016767"
FT   TOPO_DOM        20..515
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        516..536
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        537..978
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          24..104
FT                   /note="Ig-like C2-type 1"
FT   DOMAIN          107..197
FT                   /note="Ig-like C2-type 2"
FT   DOMAIN          204..298
FT                   /note="Ig-like C2-type 3"
FT   DOMAIN          299..397
FT                   /note="Ig-like C2-type 4"
FT   DOMAIN          398..503
FT                   /note="Ig-like C2-type 5"
FT   DOMAIN          580..914
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          540..572
FT                   /note="Regulatory juxtamembrane domain"
FT                   /evidence="ECO:0000250"
FT   REGION          794..816
FT                   /note="Activation loop"
FT                   /evidence="ECO:0000250"
FT   REGION          921..957
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        923..947
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        776
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10028"
FT   BINDING         586..594
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         614
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         544
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:P07333"
FT   MOD_RES         559
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:P09581"
FT   MOD_RES         697
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:P07333"
FT   MOD_RES         706
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:P07333"
FT   MOD_RES         711
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P07333"
FT   MOD_RES         721
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:P07333"
FT   MOD_RES         807
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:P07333"
FT   MOD_RES         921
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:P09581"
FT   MOD_RES         974
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:P09581"
FT   CARBOHYD        45
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        73
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        302
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        335
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        389
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        410
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        449
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        478
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        491
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        42..84
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        127..177
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        224..278
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        417..483
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
SQ   SEQUENCE   978 AA;  109264 MW;  0A68456EF56BC7E3 CRC64;
     MELGPPLVLL LATVWHGQGA PVIEPSGPEL VVEPGETVTL RCVSNGSVEW DGPISPYWTL
     DPESPGSTLT TRNATFKNTG TYRCTELEDP MAGSTTIHLY VKDPAHSWNL LAQEVTVVEG
     QEAVLPCLIT DPALKDSVSL MREGGRQVLR KTVYFFSAWR GFIIRKAKVL DSNTYVCKTM
     VNGRESTSTG IWLKVNRVHP EPPQIKLEPS KLVRIRGEAA QIVCSATNAE VGFNVILKRG
     DTKLEIPLNS DFQDNYYKKV RALSLNAVDF QDAGIYSCVA SNDVGTRTAT MNFQVVESAY
     LNLTSEQSLL QEVSVGDSLI LTVHADAYPS IQHYNWTYLG PFFEDQRKLE FITQRAIYRY
     TFKLFLNRVK ASEAGQYFLM AQNKAGWNNL TFELTLRYPP EVSVTWMPVN GSDVLFCDVS
     GYPQPSVTWM ECRGHTDRCD EAQALQVWND THPEVLSQKP FDKVIIQSQL PIGTLKHNMT
     YFCKTHNSVG NSSQYFRAVS LGQSKQLPDE SLFTPVVVAC MSVMSLLVLL LLLLLYKYKQ
     KPKYQVRWKI IERYEGNSYT FIDPTQLPYN EKWEFPRNNL QFGKTLGAGA FGKVVEATAF
     GLGKEDAVLK VAVKMLKSTA HADEKEALMS ELKIMSHLGQ HENIVNLLGA CTHGGPVLVI
     TEYCCYGDLL NFLRRKAEAM LGPSLSPGQD SEGDSSYKNI HLEKKYVRRD SGFSSQGVDT
     YVEMRPVSTS SSDSFFKQDL DKEPSRPLEL WDLLHFSSQV AQGMAFLASK NCIHRDVAAR
     NVLLTSGHVA KIGDFGLARD IMNDSNYVVK GNARLPVKWM APESILYCVY TVQSDVWSYG
     ILLWEIFSLG LNPYPGILVN NKFYKLVKDG YQMAQPVFAP KNIYSIMQSC WDLEPTRRPT
     FQQICFLLQE QARLERRDQD YANLPSSGGS SGSDSGGGSS GGSSSEPEEE SSSEHLACCE
     PGDIAQPLLQ PNNYQFAC
//
